source
- FDA issues request for information on early-phase ibogaine trial designThe FDA announced a request for information (RFI) to gather input on how to design early-phase clinical trials of ibogaine drug products. The agency is looking for comments on protocol elements su…
- Novartis pays $575 million upfront for access to Chinese biotech Abogen’s RNA platform and option on ABO-2203Novartis announced a deal with China‑based Abogen Biosciences that could be worth up to $7.8 billion. The agreement includes an upfront payment of $575 million. Under the deal, Abogen will provide…